Kravchenko, A V

Issue Section Title Abstract File
Vol 78, No 11 (2003) Editorial Development of approaches to enhancing adherence of patients withhuman immunodeficiency virus infection to antiretrovirustherapy Abstract
Vol 79, No 4 (2004) Editorial Antiretroviral therapy of acute HIV-infection Abstract
Vol 79, No 4 (2004) Editorial Secondary diseases in patients with HIV infection: 15-year follow-up Abstract
Vol 79, No 4 (2004) Editorial Characteristics of tuberculosis running with HIV-infection Abstract
Vol 79, No 11 (2004) Editorial Combined antiretroviral therapy with nevirapine of HIV-infected adults Abstract
Vol 81, No 4 (2009) Editorial Treatment of HIV infection in the Russian Federation Abstract
Vol 82, No 11 (2010) Editorial Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens Abstract
Vol 82, No 11 (2010) Editorial The course and treatment of chronic hepatitis B in HIV-infected patients Abstract
Vol 83, No 11 (2011) Editorial Diagnosis of tuberculous pericarditis in patients with HIV-infection Abstract
Vol 83, No 11 (2011) Editorial Current course of pneumocystic pneumonia in HIV-infected patients Abstract
Vol 83, No 11 (2011) Editorial Analysis of lethal outcomes in patients with newly-diagnosed tuberculosis of the respiratory organs in combination with HIV-infection Abstract
Vol 85, No 11 (2013) Editorial The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment Abstract
Vol 85, No 11 (2013) Editorial Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens Abstract
Vol 86, No 11 (2014) Editorial The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection Abstract
Vol 87, No 11 (2015) Editorial Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis Abstract

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies